DeGruttola VG - Search Results

1

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy.

Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. Bennett KK, et al. Among authors: degruttola vg. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):20-6. doi: 10.1097/00126334-200209010-00003. J Acquir Immune Defic Syndr. 2002. PMID: 12352146 Clinical Trial.

2

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy.

Marschner IC, Collier AC, Coombs RW, D'Aquila RT, DeGruttola V, Fischl MA, Hammer SM, Hughes MD, Johnson VA, Katzenstein DA, Richman DD, Smeaton LM, Spector SA, Saag MS. Marschner IC, et al. J Infect Dis. 1998 Jan;177(1):40-7. doi: 10.1086/513823. J Infect Dis. 1998. PMID: 9419168 Clinical Trial.

3

Clinical trials using HIV-1 RNA-based primary endpoints: statistical analysis and potential biases.

Marschner IC, Betensky RA, DeGruttola V, Hammer SM, Kuritzkes DR. Marschner IC, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):220-7. doi: 10.1097/00042560-199903010-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1999. PMID: 10077169

4

Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy.

Huang W, De Gruttola V, Fischl M, Hammer S, Richman D, Havlir D, Gulick R, Squires K, Mellors J. Huang W, et al. J Infect Dis. 2001 May 15;183(10):1455-65. doi: 10.1086/320192. Epub 2001 Apr 24. J Infect Dis. 2001. PMID: 11319681

5

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group.

D'Aquila RT, Johnson VA, Welles SL, Japour AJ, Kuritzkes DR, DeGruttola V, Reichelderfer PS, Coombs RW, Crumpacker CS, Kahn JO, Richman DD. D'Aquila RT, et al. Ann Intern Med. 1995 Mar 15;122(6):401-8. doi: 10.7326/0003-4819-122-6-199503150-00001. Ann Intern Med. 1995. PMID: 7856987 Clinical Trial.

6

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens.

Gilbert PB, Hanna GJ, De Gruttola V, Martinez-Picado J, Kuritzkes DR, Johnson VA, Richman DD, D'Aquila RT. Gilbert PB, et al. AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1325-36. doi: 10.1089/08892220050140874. AIDS Res Hum Retroviruses. 2000. PMID: 11018852 Clinical Trial.

7

Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.

Gaolathe T, Wirth KE, Holme MP, Makhema J, Moyo S, Chakalisa U, Yankinda EK, Lei Q, Mmalane M, Novitsky V, Okui L, van Widenfelt E, Powis KM, Khan N, Bennett K, Bussmann H, Dryden-Peterson S, Lebelonyane R, El-Halabi S, Mills LA, Marukutira T, Wang R, Tchetgen EJ, DeGruttola V, Essex M, Lockman S; Botswana Combination Prevention Project study team. Gaolathe T, et al. Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24. Lancet HIV. 2016. PMID: 27126489 Free PMC article.

8

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.

Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW; AIDS Clinical Trials Group 398 Study Team. Hammer SM, et al. JAMA. 2002 Jul 10;288(2):169-80. doi: 10.1001/jama.288.2.169. JAMA. 2002. PMID: 12095381 Clinical Trial.

9

Perspective: human immunodeficiency virus type 1 (HIV-1) RNA end points in HIV clinical trials: issues in interim monitoring and early stopping.

Zackin R, Marschner I, Andersen J, Cowles MK, De Gruttola V, Hammer S, Fischl M, Cotton D. Zackin R, et al. J Infect Dis. 1998 Mar;177(3):761-5. doi: 10.1086/514244. J Infect Dis. 1998. PMID: 9498459 Review.

10

Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.

De Gruttola V, Wulfsohn M, Fischl MA, Tsiatis A. De Gruttola V, et al. J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):359-65. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8095980 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters